Orion Portfolio Solutions LLC Has $1.23 Million Stake in Humana Inc. (NYSE:HUM)

Orion Portfolio Solutions LLC grew its holdings in Humana Inc. (NYSE:HUM) by 3.7% during the fourth quarter, Holdings Channel.com reports. The firm owned 4,834 shares of the insurance provider’s stock after acquiring an additional 171 shares during the period. Orion Portfolio Solutions LLC’s holdings in Humana were worth $1,226,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Vanguard Group Inc. raised its holdings in shares of Humana by 15.8% in the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock valued at $3,254,899,000 after buying an additional 1,751,857 shares during the last quarter. Norges Bank bought a new position in shares of Humana in the fourth quarter worth about $416,202,000. Pzena Investment Management LLC lifted its position in shares of Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock worth $915,736,000 after purchasing an additional 1,103,132 shares in the last quarter. Boston Partners grew its stake in shares of Humana by 435.8% during the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock valued at $279,236,000 after purchasing an additional 893,637 shares during the last quarter. Finally, Artisan Partners Limited Partnership increased its holdings in shares of Humana by 83.4% in the fourth quarter. Artisan Partners Limited Partnership now owns 673,715 shares of the insurance provider’s stock valued at $170,928,000 after purchasing an additional 306,433 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of HUM opened at $253.37 on Friday. The stock has a 50 day simple moving average of $267.58 and a 200 day simple moving average of $272.13. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a market capitalization of $30.58 billion, a PE ratio of 25.46, a P/E/G ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.40%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio is 35.58%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Piper Sandler lifted their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Barclays lifted their price objective on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Morgan Stanley cut their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. StockNews.com downgraded shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, March 18th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Eighteen equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $280.17.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.